The mammary tumors of the MTB-IGFIR transgenic mice that recur following IGF-IR downregulation cluster most closely with murine mammary tumor models presenting with basal/myoepithelial features and primarily with human claudin-low tumors (unpublished observation). This evidence concerns the gene IGF1R and breast cancer.